Source: Transplant infectious disease. Unidade: FM
Subjects: HEPATITE B, MEDULA ÓSSEA, ESTUDOS RETROSPECTIVOS, ANTICORPOS MONOCLONAIS, REPLICAÇÃO VIRAL, HOSPEDEIRO IMUNOCOMPROMETIDO, IDOSOS, ANTIVIRAIS
ABNT
BUZO, Bruno Fernando et al. Hepatitis B virus among hematopoietic stem cell transplant recipients: antiviral impact in seroconversion, engraftment, and mortality in a Latin American center. Transplant infectious disease, v. 22, n. 2, 2020Tradução . . Disponível em: https://doi.org/10.1111/tid.13243. Acesso em: 18 nov. 2024.APA
Buzo, B. F., Ramos, J. F., Rossetti, R. A. M., Salles, N., Medrone-junior, A., Rocha, V. G., & Nastri, A. C. de S. S. (2020). Hepatitis B virus among hematopoietic stem cell transplant recipients: antiviral impact in seroconversion, engraftment, and mortality in a Latin American center. Transplant infectious disease, 22( 2). doi:10.1111/tid.13243NLM
Buzo BF, Ramos JF, Rossetti RAM, Salles N, Medrone-junior A, Rocha VG, Nastri AC de SS. Hepatitis B virus among hematopoietic stem cell transplant recipients: antiviral impact in seroconversion, engraftment, and mortality in a Latin American center [Internet]. Transplant infectious disease. 2020 ; 22( 2):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/tid.13243Vancouver
Buzo BF, Ramos JF, Rossetti RAM, Salles N, Medrone-junior A, Rocha VG, Nastri AC de SS. Hepatitis B virus among hematopoietic stem cell transplant recipients: antiviral impact in seroconversion, engraftment, and mortality in a Latin American center [Internet]. Transplant infectious disease. 2020 ; 22( 2):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/tid.13243